Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Acumen Pharmaceuticals Inc., 3 years.
Acumen Pharmaceuticals Inc.
Director
Taysha Gene Therapies Inc.
Director
Verrica Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 3, 2026 | Acumen Pharmaceuticals Inc. | Grant or award | +35,500 | — | — |
| Jun 1, 2026 | Taysha Gene Therapies Inc. | Grant or award | +21,335 | — | — |
| Jun 4, 2025 | Acumen Pharmaceuticals Inc. | Grant or award | +12,800 | — | — |
| Jun 2, 2025 | Taysha Gene Therapies Inc. | Grant or award | +56,623 | — | — |
| Nov 26, 2024 | Verrica Pharmaceuticals Inc. | Gift | +50,000 | — | — |
| Nov 22, 2024 | Verrica Pharmaceuticals Inc. | Open-market purchase | +1,123,595 | — | — |
| May 29, 2024 | Taysha Gene Therapies Inc. | Grant or award | +49,220 | — | — |
| Aug 16, 2023 | Taysha Gene Therapies Inc. | Open-market purchase | +388,889 | $0.90 | $350,000 |
| Aug 16, 2023 | Taysha Gene Therapies Inc. | Open-market purchase | +388,889 | $0.90 | $350,000 |
| Aug 16, 2023 | Taysha Gene Therapies Inc. | Gift | +50,000 | — | — |
Questions about John A. Stalfort III
What boards is John A. Stalfort III on?
John A. Stalfort III sits on the boards of Acumen Pharmaceuticals Inc., Taysha Gene Therapies Inc. and Verrica Pharmaceuticals Inc.
How long has John A. Stalfort III served on boards?
Our records show at least 9 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.